Dr. Milton Werner
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Milton Werner
Dr. Milton Werner is recorded as CEO at Inhibikase Therapeutics, Inc. (IKT).
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inhibikase Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark Iwicki CEO, Board Member
- Amit Munshi Chairman, Board Member
- Roberto Bellini Chairman, Board Member
- David McIntyre CFO
- Arvind Kush Board Member
- David Canner Board Member
- Dennis Berman Board Member
- Vincent Aurentz Board Member
Recent activity
No call appearances or filed executive changes recorded yet.